Evidence map›Paper›PMID 30247785›Full record

ArticleScandinavian journal of immunology2018

IFN-λ4 inhibits HIV infection of macrophages through signalling of IFN-λR1/IL-10R2 receptor complex.

Qi-Jian Su, Xu Wang, Run-Hong Zhou, Le Guo, Hang Liu, Jie-Liang Li, Wen-Zhe Ho

Open access · bronzeAbstract read
In one paragraph

Article in Scandinavian journal of immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Mechanisms of Differential Signal Transduction by IFNLR1 Variants.bioRxiv : the preprint server for biology · 2025
    Article
  4. Review
  5. Article
  6. IFN-λ3 is induced byInfection and immunity · 2024
    Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Qi-Jian SuRuikang Hospital, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.ORCID http://orcid.org/0000-0002-6194-0317
Xu WangDepartment of Pathology and Laboratory Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
Run-Hong ZhouSchool of Basic Medical Sciences/State Key Laboratory of Virology, Wuhan University, Wuhan, Hubei, China.
Le GuoSchool of Basic Medical Sciences/State Key Laboratory of Virology, Wuhan University, Wuhan, Hubei, China.
Hang LiuSchool of Basic Medical Sciences/State Key Laboratory of Virology, Wuhan University, Wuhan, Hubei, China.
Jie-Liang LiDepartment of Pathology and Laboratory Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
Wen-Zhe HoDepartment of Pathology and Laboratory Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
Wuhan University · CNTemple University · USGuangxi University of Chinese Medicine · CN

Funding

Opioids, HIV/HCV and Host Cell Innate ImmunityR01DA022177 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2007 to 2017
$2.9M
Methamphetamine, Innate Immunity and HIVR01DA041302 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2016 to 2020
$1.8M
Opioids, Extracellular Vesicles and BBB Innate ImmunityR21DA042373 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2017 to 2018
$436k
Role of Exosomes in the Crosstalk Between Brain Endothelium and HIV NeuroinvasionR21MH109385 · NIMH · TEMPLE UNIV OF THE COMMONWEALTH · PI LI, JIELIANG · 2016 to 2017
$429k
Exosome in Methamphetamine and HIV-associated NeurodegenerationR21DA040329 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI LI, JIELIANG · 2015 to 2016
$427k
National Natural Science Foundation of China 81360258National Natural Science Foundation of China 81571962NIDA NIH HHS R01 DA022177NIDA NIH HHS R01 DA041302NIDA NIH HHS R21 DA040329NIDA NIH HHS R21 DA042373NIH HHS DA022177NIH HHS DA 040329NIH HHS DA041302NIH HHS MH109385NIMH NIH HHS R21 MH109385
6 · The paper itself

Abstract

The recently discovered IFN-λ4 has been found to have antiviral activity against several viruses. However, it's unknown whether IFN-λ4 can inhibit HIV infection. Here, we show that IFN-λ4 could suppress HIV infection of macrophages. This IFN-λ4-mediated HIV inhibition was compromised by the antibodies against IFN-λ receptor complex, IFN-λR1/IL-10R2. IFN-λ4 enhanced the phosphorylation of STAT1, and induced antiviral interferon-stimulated genes. These findings indicated that IFN-λ4 can inhibit HIV via JAK/STAT signalling pathway.

Indexed as

Anti-HIV AgentsHIV InfectionsHumansInterferon LambdaInterleukin-10 Receptor beta SubunitInterleukinsIn Vitro TechniquesMacrophagesReceptors, CytokineReceptors, InterferonRecombinant ProteinsSignal TransductionSTAT1 Transcription FactorVirus ReplicationAnti-HIV AgentsIFNL4 protein, humanIFNLR1 protein, humanIL10RB protein, humanInterferon LambdaInterleukin-10 Receptor beta SubunitInterleukinsReceptors, CytokineReceptors, InterferonRecombinant ProteinsSTAT1 protein, humanSTAT1 Transcription Factor

Identifiers

PMID30247785
PMCPMC6286684
OpenAlexW2893735318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.